Patents by Inventor Daniela Schlatzer

Daniela Schlatzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attractin and lumican biomarkers in idiopathic pneumonia syndrome
    Patent number: 10627414
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: April 21, 2020
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
  • PGLYRP2 BIOMARKER IN IDIOPATHIC PNEUMONIA SYNDROME
    Publication number: 20180067130
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 8, 2018
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
  • PGLYRP2 biomarker in idiopathic pneumonia syndrome
    Patent number: 9810696
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: November 7, 2017
    Assignee: Case Western Reserve University
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
  • PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR AUTOIMMUNE AND ALLOIMMUNE DISEASES
    Publication number: 20150099664
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
  • Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C
    Patent number: 8911960
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: December 16, 2014
    Assignee: Case Western Reserve University
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer
  • PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR AUTOIMMUNE AND ALLOIMMUNE DISEAES
    Publication number: 20120077209
    Abstract: A method for characterizing the risk a subject will develop an autoimmune and/or alloimmune disease following tissue transplant includes obtaining a biological sample from the subject, wherein the subject has received the tissue transplant determining in the biological sample a level of at least one protein selected from Tables 1-4, comparing the measured level of the at least one protein to a control value, and characterizing a subject as at greater risk of developing an autoimmune disease and/or alloimmune disease if the level of at least one protein determined is increased or decreased compared to the control value.
    Type: Application
    Filed: June 1, 2010
    Publication date: March 29, 2012
    Inventors: Mark Chance, Kenneth Cooke, Daniela Schlatzer